Paper30002297
Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization.
Zayed MF and 4 others. Molecules, 2018. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization. Papers, record 30002297. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30002297
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ErbB Receptors | Major topic |
| Molecular Docking Simulation | Major topic |
| Protein Kinase Inhibitors | Major topic |
| Quinazolines | Major topic |
| Tubulin | Major topic |
| Tubulin Modulators | Major topic |
| Humans | |
| MCF-7 Cells |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25174978 | Synthesis and antihypertensive activity of novel quinazolin-4(3H)-one derivatives. | Cent Nerv Syst Agents Med Chem | 2014 | https://conductscience.org/library/papers/25174978 | PubMed |
| 2 | 10592235 | The Protein Data Bank. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/10592235 | PubMed |
| 3 | 18950904 | Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs. | Eur J Med Chem | 2009 | https://conductscience.org/library/papers/18950904 | PubMed |
| 4 | 19664865 | Synthesis, characterization and derivatization of some novel types of mono- and bis-imidazolidineiminothiones and imidazolidineiminodithiones with antitumor, antiviral, antibacterial and antifungal activities--part I. | Eur J Med Chem | 2009 | https://conductscience.org/library/papers/19664865 | PubMed |
| 5 | 16971132 | Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. | Bioorg Med Chem | 2006 | https://conductscience.org/library/papers/16971132 | PubMed |
| 6 | 24801610 | Discovery of biarylaminoquinazolines as novel tubulin polymerization inhibitors. | J Med Chem | 2014 | https://conductscience.org/library/papers/24801610 | PubMed |
| 7 | 24648828 | Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. | Saudi Pharm J | 2014 | https://conductscience.org/library/papers/24648828 | PubMed |
| 8 | 1731931 | Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes. | Biochemistry | 1992 | https://conductscience.org/library/papers/1731931 | PubMed |
| 9 | 23487401 | Design, synthesis and biological evaluation studies of novel quinazoline derivatives as cytotoxic agents. | Drug Res (Stuttg) | 2013 | https://conductscience.org/library/papers/23487401 | PubMed |
| 10 | 15072839 | Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones. | Eur J Med Chem | 2004 | https://conductscience.org/library/papers/15072839 | PubMed |
| 11 | 28215601 | Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor. | Bioorg Chem | 2017 | https://conductscience.org/library/papers/28215601 | PubMed |
| 12 | 27589739 | The Impact of Soy Isoflavones on MCF-7 and MDA-MB-231 Breast Cancer Cells Using a Global Metabolomic Approach. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27589739 | PubMed |
| 13 | 29891789 | Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29891789 | PubMed |
| 14 | 29385728 | The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29385728 | PubMed |
| 15 | 12735990 | Synthesis and antihyperglycemic activity of suitably functionalized 3H-quinazolin-4-ones. | Bioorg Med Chem | 2003 | https://conductscience.org/library/papers/12735990 | PubMed |
| 16 | 22551678 | New quinazolinone-pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies. | Eur J Med Chem | 2012 | https://conductscience.org/library/papers/22551678 | PubMed |
| 17 | 28838691 | Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and α-glucosidase. | Bioorg Med Chem Lett | 2017 | https://conductscience.org/library/papers/28838691 | PubMed |
| 18 | 20724039 | Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones. | Eur J Med Chem | 2010 | https://conductscience.org/library/papers/20724039 | PubMed |
| 19 | 12384534 | ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. | Cancer Res | 2002 | https://conductscience.org/library/papers/12384534 | PubMed |
| 20 | 20510483 | Synthesis of some new 4(3H)-quinazolinone-2-carboxaldehyde thiosemicarbazones and their metal complexes and a study on their anticonvulsant, analgesic, cytotoxic and antimicrobial activities - part-1. | Eur J Med Chem | 2010 | https://conductscience.org/library/papers/20510483 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42196461 | Synthesis and Biological Evaluation of New Quinazolin-4(3H)-One-Coumarin Hybrids Designed as Anticancer and Antibacterial Agents. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196461 | PubMed |
| 41599658 | Design, Synthesis, and Biological Evaluation of N-Acyl-Hydrazone-Linked Quinazolinone Derivatives with Antioxidant, Antimicrobial, and Anticancer Potential. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41599658 | PubMed |
| 41379296 | Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review. | Mol Divers | 2026 | https://conductscience.org/library/papers/41379296 | PubMed |
| 41053651 | Novel anticancer effect of substituted imidazole derivatives against urothelial carcinoma: integrating In vitro screening and molecular docking for target kinases. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41053651 | PubMed |
| 40106127 | Spiroindoline quinazolinedione derivatives as inhibitors of P-glycoprotein: potential agents for overcoming multidrug resistance in cancer therapy. | Mol Divers | 2025 | https://conductscience.org/library/papers/40106127 | PubMed |
| 40001513 | Quinazolinones as Potential Anticancer Agents: Synthesis and Action Mechanisms. | Biomolecules | 2025 | https://conductscience.org/library/papers/40001513 | PubMed |
| 39390838 | Anticancer Drug Discovery from Natural Compounds Targeting PI3K/AKT/mTOR Signaling Pathway. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39390838 | PubMed |
| 38899242 | Quinazoline Derivatives as Targeted Chemotherapeutic Agents. | Cureus | 2024 | https://conductscience.org/library/papers/38899242 | PubMed |
| 37259442 | Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37259442 | PubMed |
| 36790582 | New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization. | Mol Divers | 2024 | https://conductscience.org/library/papers/36790582 | PubMed |
| 35516563 | Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids. | RSC Adv | 2020 | https://conductscience.org/library/papers/35516563 | PubMed |
| 35409361 | A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409361 | PubMed |
| 35269887 | MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents-A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269887 | PubMed |
| 34074193 | Synthesis and preliminary structure-activity relationship study of 3-methylquinazolinone derivatives as EGFR inhibitors with enhanced antiproliferative activities against tumour cells. | J Enzyme Inhib Med Chem | 2021 | https://conductscience.org/library/papers/34074193 | PubMed |
| 31967481 | Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment. | J Enzyme Inhib Med Chem | 2020 | https://conductscience.org/library/papers/31967481 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| NR4A3 | 8013 | PubTator's text mining | https://conductscience.org/library/genes/8013 | NCBI Gene |
| TYMS | 7298 | PubTator's text mining | https://conductscience.org/library/genes/7298 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30002297
GET https://conductscience.org/api/papers/v1/30002297/authors